ChickenStock Research
US SEC filing analysis
Read reviewed analyses of US SEC filings in English. Each report shows the form, the filing date, the scope of the analysis and the original filing.
Stock, IR and earnings analyses are available in Korean only. Korean analysis reports →
Find a company
Search by company name, ticker or report title.
US filing forms
Includes amendments (/A).Events and earnings releases · Reports events such as earnings releases, agreements and management changes. Not every 8-K is an earnings release.
US filing analysis · 8-K
Sorted by SEC acceptance time (filing date when unavailable). Page 35 · 30 shown · up to 30 per page
CAT
Caterpillar said sales and revenues for Q2 2025 were $16.6 billion, a 1% decrease from $16.7 billion in the prior-year period, and profit per share was $4.62, or $4.72 adjusted, compared with $5.48, or $5.99 adjusted, in the prior-year period.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 5, 2025
CaterpillarCAT$796.18-2.17%
ANET
Arista Networks said revenue for Q2 2025 ended June 30 was $2.205 billion, up 10.0% from Q1 2025 and up 30.4% from Q2 2024, and GAAP net income was $888.8 million, or $0.70 per diluted share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 5, 2025
Arista NetworksANET$215.36+4.09%
AMGN
On August 5, 2025, Amgen issued a press release announcing its unaudited results of operations for the 3 and 6 months ended June 30, 2025 and its unaudited financial position as of June 30, 2025.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 5, 2025
AmgenAMGN$402.6-0.09%
VRTX
Vertex said total revenue for Q2 2025 (the 3 months ended June 30, 2025) was $2.96 billion, a 12% increase compared to Q2 2024. The company cited continued performance of cystic fibrosis therapies and early contributions from the three ongoing product launches as factors for the increase.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 4, 2025
Vertex PharmaceuticalsVRTX$503.25-0.47%
TSN
Tyson Foods said third-quarter sales were $13,884 million, up from $13,353 million in the prior-year quarter, and GAAP operating income was $260 million, down from $341 million in the prior-year quarter.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 4, 2025
Tyson FoodsTSN$52.34+1.24%
SPG
Simon Property Group said it issued a press release on August 4, 2025 containing information on earnings for the quarter ended June 30, 2025 and other matters. The press release was furnished as Exhibit 99.1.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 4, 2025
Simon Property GroupSPG$199.61+1.02%
PLTR
Palantir said revenue for Q2 2025 ended June 30 was $1.004 billion, up 48% year-over-year and 14% quarter-over-quarter. U.S. revenue was $733 million and U.S. commercial revenue was $306 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 4, 2025
Palantir TechnologiesPLTR$194.12+1.07%
MLM
Martin Marietta said it agreed to transfer its Midlothian cement plant, related cement terminals and North Texas ready-mixed concrete assets to Quikrete in exchange for aggregates operations producing approximately 20 million tons annually in Virginia, Missouri, Kansas and Vancouver, British Columbia, and $450 million in cash.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 4, 2025
Martin Marietta MaterialsMLM$479.01-2.04%
AXON
Axon Enterprise said Q2 2025 revenue was $669 million, up 33% year over year, and raised its full-year revenue outlook to $2.65 billion to $2.73 billion from $2.60 billion to $2.70 billion.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 4, 2025
Axon EnterpriseAXON$418.62+1.65%
TROW
T. Rowe Price said assets under management at the end of Q2 were $1.68 trillion, an increase of $110.5 billion during the quarter, and net client outflows in the same quarter were $14.9 billion.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 1, 2025
T. Rowe PriceTROW$104.23+0.15%
REGN
Regeneron said total revenues for Q2 2025 were $3,676 million, up 4% from $3,547 million in the prior-year quarter, GAAP diluted earnings per share were $12.81, and non-GAAP diluted earnings per share were $12.89.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 1, 2025
Regeneron PharmaceuticalsREGN$742.12+0.46%
LYB
The company reported net income for Q2 2025 of $115 million, or $0.34 per diluted share, and net income excluding identified items of $202 million, or $0.62 per share. EBITDA for the quarter was $606 million, or $715 million excluding identified items.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 1, 2025
LyondellBasellLYB$60.34+3.16%
CL
Colgate-Palmolive said net sales for Q2 2025 increased $5,110 million, up 1.0%, and diluted EPS on a GAAP basis increased to $0.91, up 2%. Organic sales increased 1.8%.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Aug 1, 2025
Colgate-PalmoliveCL$87.25+1.23%
SYK
Stryker said reported net sales for Q2 2025 increased 11.1% to $6.0 billion, and organic net sales increased 10.2%. The company said organic growth included 9.7% from increased unit volume and 0.5% from higher prices.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
StrykerSYK$276.97+0.57%
RDDT
Reddit said revenue for the 3 months ended June 30, 2025 was $500 million, an increase of 78% from $281 million in the prior year. Ad revenue increased 84% to $465 million, and other revenue increased 24% to $35 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
RedditRDDT$152.71+2.52%
PCG
PG&E said income available for common shareholders on a GAAP basis for Q2 2025 was $521 million, or $0.24 per share, and non-GAAP core earnings were $674 million, or $0.31 per share, the same per-share amounts as Q2 2024.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
PG&EPCG$12.79+2.32%
ICE
The company said that for Q2 2025 ended June 30, 2025, total revenues, less transaction-based expenses, were $2,543 million, compared with $2,317 million in the prior year period, operating income was $1,297 million, compared with $1,066 million in the prior year period, and diluted EPS were $1.48, compared with $1.10 in the prior year period.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
Intercontinental ExchangeICE$155.35+1.81%
HWM
Howmet Aerospace said Q2 2025 revenue was $2.05 billion, up 9% year over year, and net income was $407 million, or $1.00 per share, compared with Q2 2024 net income of $266 million, or $0.65 per share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
Howmet AerospaceHWM$222.56-0.09%
HII
Huntington Ingalls Industries said sales and service revenues for Q2 2025 were $3,082 million, up 3.5% from Q2 2024, while operating income was $163 million with an operating margin of 5.3%, compared to $189 million and 6.3% in the prior-year period.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
Huntington Ingalls IndustriesHII$265.02+1.67%
CVS
CVS Health said total revenues for the 3 months ended June 30, Q2 2025 were $98,915 million, up 8.4% from $91,234 million in the prior year. GAAP diluted EPS was $0.80, down from $1.41 in the prior year, while Adjusted EPS was $1.81.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
CVS HealthCVS$86.43-0.67%
COIN
Coinbase announced its financial results for the quarter ended June 30, 2025 in a shareholder letter dated July 31, 2025.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
CoinbaseCOIN$185.74-1.32%
CMCSA
Comcast said net income attributable to Comcast for Q2 2025 was $11,123 million, compared to $3,929 million in the prior year period. The company said this included a $9.4 billion pretax gain from the sale of its interest in Hulu.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
ComcastCMCSA$21.56-0.05%
CI
Cigna said total revenues for Q2 2025 increased 11% to $67.2 billion, shareholders' net income was $1.5 billion, or $5.71 per share, and adjusted income from operations was $1.9 billion, or $7.20 per share.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
CignaCI$274.37+1.14%
BE
Bloom Energy said revenue for Q2 2025 was $401.2 million, an increase of 19.5% compared to Q2 2024 of $335.8 million. Gross margin was 26.7%, an increase of 6.3 percentage points compared to 20.4% in Q2 2024.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
Bloom EnergyBE$295.78+3.19%
APD
Air Products said third quarter fiscal 2025 GAAP EPS was $3.24, up 4% from the prior year, and adjusted EPS was $3.09, down 3%. GAAP operating income was $791 million, up 7%, and adjusted operating income was $741 million, flat.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
Air ProductsAPD$281+0.55%
AAPL
Apple posted net sales of $94,036 million, net income of $23,434 million and diluted earnings per share of $1.57 for the 3 months ended June 28, 2025 in fiscal 2025 Q3. Net sales in the prior-year period were $85,777 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 31, 2025
AppleAAPL$333.63+0.22%
VRSK
Verisk said Q2 2025 revenue was $773 million, up 7.8%, and net income was $253 million, down 17.7%. The company cited net gains in the prior year period related to sales of its healthcare and specialized market businesses and the early extinguishment of debt as factors in the net income decrease.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 30, 2025
Verisk AnalyticsVRSK$175.49+4.04%
TT
Trane Technologies said net revenues for Q2 2025 were $5,746 million, compared with $5,307 million in the prior-year period, an increase of 8%, and GAAP continuing EPS was $3.87; adjusted continuing EPS was $3.88, up 18%.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 30, 2025
Trane TechnologiesTT$469.94+0.57%
TER
Teradyne said revenue for Q2 2025 was $652 million, of which Semiconductor Test was $492 million, Robotics $75 million and Product Test $85 million. Revenue in the prior quarter was $685.7 million and in the year-ago quarter was $729.9 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 30, 2025
TeradyneTER$398.72-3.17%
SW
Smurfit Westrock said net sales for the 3 months ended June 30, 2025 were $7,940 million and net loss was $26 million, with a net income margin of negative 0.3%. In the prior-year period, net sales were $2,969 million and net income was $132 million.
US filing analysisUS8-K · Current reportPublished Oct 8, 2026SEC filing date Jul 30, 2025
Smurfit WestrockSW$41.45+0.39%
These reports are reference information based on public facts such as filings and prices. They do not recommend buying or selling any security.